Novel Exosome-Based Therapies for Treating Colorectal Cancer
Time: 2:10 pm
day: Conference Day Two
Details:
- T cells costimulatory functions are affected by tumor-intrinsic mechanism in colorectal cancer leading to host immune suppression
- Modified colorectal cancer tumor EVs without immune suppressive microRNAs can stimulate antitumor immunity and has therapeutic potential in advanced disease models
- Harnessing the immunogenicity of modified tumor EVs can be developed as a novel therapeutic strategy to reduce cancer immunotherapy resistance
NEW DATA!
Speakers:
